Tech Company Financing Transactions
ReproCELL Funding Round
ReproCELL secured a investment round on 10/22/2025. Investors included Maryland Stem Cell Research Fund.
Transaction Overview
Company Name
Announced On
10/22/2025
Transaction Type
Debt
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The addition of this capability will enable REPROCELL to offer two distinct GMP technologies under one roof. In 2024, MSCRF funded a grant for the development of the "Enhancement of Capabilities of Existing Cytocentric® Xvivo System Model 2 from BioSpherix", which is a closed GMP system designed for manufacturing master cell banks.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
9000 Virginia Manor Road 207
Beltsville, MD 20705
USA
Beltsville, MD 20705
USA
Phone
Website
Email Address
Overview
Our portfolio includes an extensive product catalog to support stem cell research and 3D bioengineered tissues, a commercial biorepository of ethically-sourced human tissues, extensive clinical networks across the USA and Europe that enable our contract research services in human ex vivo living tissues, and our capability to supply induced pluripotent stem cells (iPSCs) for both research and clinical applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chikafumi Yokoyama
Chief Operating Officer
Daisuke Usui
Browse more venture capital transactions:
Prev: 10/22/2025: roclub venture capital transaction
Next: 10/22/2025: RedHill Biopharma venture capital transaction
Share this article
About Database of VC Transactions
We report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs